Avg closing price

Price range

7 Cathie Wood Fate Therapeutics Inc transactions

Avg closing price
Price range
Increased shares by 14.2% (+929 Thousand shares) Q2 2021

Avg closing price

$80.58

Price range

$67.25 - $92.52
Increased shares by 125.9% (+3.65 Million shares) Q1 2021

Avg closing price

$95.82

Price range

$72.16 - $117.40
Increased shares by 101.5% (+1.46 Million shares) Q4 2020

Avg closing price

$62.10

Price range

$38.09 - $100.95
Increased shares by 41.2% (+420 Thousand shares) Q3 2020

Avg closing price

$34.92

Price range

$30.41 - $40.50
Increased shares by 83.7% (+465 Thousand shares) Q2 2020

Avg closing price

$29.80

Price range

$20.21 - $35.23
Increased shares by 28.8% (+124 Thousand shares) Q1 2020

Avg closing price

$25.29

Price range

$17.28 - $31.88
New holding (+431 Thousand shares) Q4 2019

Avg closing price

$15.88

Price range

$13.39 - $20.73

News about Fate Therapeutics Inc and Cathie Wood

Recent Poor Results Have Made This Promising Cathie Wood Pick a Bargain

Recent Poor Results Have Made This Promising Cathie Wood Pick a Bargain

Positive news versus poor clinical trial results may determine the future of Fate Therapeutics.

The Motley Fool The Motley Fool, 3 days ago

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!